| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |